1.13

3.67% 0.04

After Hours: 1.17 0.04 +3.54%

Abvc Biopharma Inc (ABVC)

Overview News Price History Financials Why ABVC Down? Discussions Forecast Stock Split

Abvc Biopharma Inc stock is traded at $1.13, with a volume of 89,253. It is up +3.67% in the last 24 hours and up +41.27% over the past month. ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

Previous Close:

$1.09

Open:

$1.08

24h Volume:

89,253

Relative Volume:

0.63

Market Cap:

$30.12M

Revenue:

$2,000

Net Income/Loss:

$-9.12M

P/E Ratio:

-2.9026

EPS:

-0.3893

Net Cash Flow:

$-3.35M

1W Performance:

-2.59%

1M Performance:

+41.27%

6M Performance:

+4.63%

1Y Performance:

-63.78%

1-Day Range:

$1.0501

$1.16

1-Week Range:

$1.0501

$1.2278

52-Week Range:

$0.7069

$3.40

Abvc Biopharma Inc Stock (ABVC) Company Profile

Name

Abvc Biopharma Inc

Sector

Healthcare (1067)

Industry

Biotechnology (595)

Phone

510-668-0881

Address

44370 OLD WARM SPRINGS BLVD., FREMONT

Employee

Twitter

Next Earnings Date

2026-10-30

Latest SEC Filings

ABVC's Discussions on Twitter

Compare ABVC vs VRTX, REGN, MRNA, ARGX, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ABVC Abvc Biopharma Inc	1.13	30.12M	2,000	-9.12M	-3.35M	-0.3893
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Abvc Biopharma Inc Stock (ABVC) Latest News

Sep 11, 2026

Director stake could rise to about 18.86% if ABVC BioPharma (ABVC) OKs stock-for-land deal - Stock Titan

Sep 11, 2026

Aug 28, 2026

ABVC Q1 2025 Earnings: Net Loss of $0.06 Per Share as Clinical-Stage Pipeline AdvancesPre-Earnings Setup - dars.gov.et

Aug 28, 2026

Aug 27, 2026

ABVC BioPharma Completes BioKey Spin-Off, Distributing 15% Stake - Minichart

Aug 27, 2026

Aug 26, 2026

ABVC (ABVC) Financial Update: The Company Lists Its Latest Available Figures on the Day; Stock Move: Shares Finish 4.76% Lower in the Latest ReadingTangible Book Value - dars.gov.et

Aug 26, 2026

Aug 25, 2026

ABVC BioPharma (NASDAQ: ABVC) puts 6.6M-share land deal to a shareholder vote - Stock Titan

Aug 25, 2026

Aug 23, 2026

ABVC (ABVC) Today: Moves 1.11% Down to $0.89 in the Current Update; Trading Range: $0.85 and $0.93 Define the Nearby Reference Levels in the Latest SessionRetail Sentiment - vinanet.vn

Aug 23, 2026

Aug 20, 2026

ABVC BioPharma, Inc. completed the Spin-Off of BioKey, Inc. - marketscreener.com

Aug 20, 2026

Aug 19, 2026

ABVC (ABVC) Earnings Report: The Latest Financial Metrics Are Now Available in the Latest Session; Trading Response: Shares Finish 8.39% Up in the Latest SessionNet Income Trends - vinanet.vn

Aug 19, 2026

Aug 18, 2026

ABVC BioPharma (ABVC) Slides 5.56% to $0.85 as Micro-Cap Biotech Faces Selling PressureGap Fill Strategy - vinanet.vn

Aug 18, 2026

Aug 15, 2026

ABVC Q1 2025 Earnings: Net Loss of -$0.06 Per Share, Stock Slips 6.2%Earnings Growth Forecast - vinanet.vn

Aug 15, 2026

ABVC BioPharma (ABVC) Slips 6.2% to $0.90 as Selling Pressure Builds Near Key SupportInstitutional Buy Signals - vinanet.vn

Aug 15, 2026

ABVC BioPharma (ABVC) Declines 6.2% to $0.90, Testing Key SupportVolatility Smile - vinanet.vn

Aug 15, 2026

Aug 14, 2026

ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView

Aug 14, 2026

Aug 12, 2026

ABVC BioPharma (ABVC) plans new equity plan and up to 6.6M-share land deal - Stock Titan

Aug 12, 2026

ABVC BIOPHARMA, INC. Q2 2026: Revenue $0 EPS $(0.03) — 10-Q Summary - TradingView

Aug 12, 2026

ABVC BioPharma (ABVC) flags going concern risk after Q2 2026 cash drain - Stock Titan

Aug 12, 2026

ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21 - TradingView

Aug 12, 2026

Form 8K ABVC Biopharma Inc For: 12 August By Investing.com - Investing.com Nigeria

Aug 12, 2026

ABVC BioPharma (ABVC) Financials 2026Income Statement and Balance Sheet - MarketBeat

Aug 12, 2026

Aug 11, 2026

ABVC Q1 2025 Earnings: Reported -$0.06 EPS as Clinical-Stage Pipeline Continues Without RevenueEBITDA Estimate Trend - dars.gov.et

Aug 11, 2026

Aug 10, 2026